2024 annual financial data
Odyssey Therapeutics 2024 Operating margin
Direct answer
Operating margin was -3,023.77%.
Operating income was -135,223,000 USD and net income was -129,321,000 USD.
Operating cash flow was -117,471,000 USD.
Get free Odyssey Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,472,000 USD
- Operating income
- -135,223,000 USD
- Net income
- -129,321,000 USD
- Operating cash flow
- -117,471,000 USD